Journal September 16, 2026 6 min read

GHK-Cu: mechanism of action

GHK-Cu is a copper(II) tripeptide complex studied for its catalytic, antioxidant and signalling activity. This page sets out the proposed mechanisms and the models in which they were observed.

peptides-pro Editorial

GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine, also written Gly-His-Lys-Cu or GHK:Cu. It belongs to the class of copper-binding peptide complexes, in which the imidazole nitrogen of the histidine residue and the terminal amine and amide nitrogens chelate a single Cu(II) ion. The parent tripeptide occurs naturally in human plasma and urine [11]. The evidence block used for this page does not supply a sequence string, molecular formula or molecular weight, so none is stated here.

The mechanistic work centres on copper-dependent redox and catalytic chemistry together with modulation of inflammatory signalling cascades, most explicitly the SIRT1/STAT3 axis in intestinal epithelium and the DAF-16/SKN-1 stress-response pathways in invertebrate models.

Research Studies

GHK-Cu and laccase-like catalytic activity in colorimetric sensing

GHK-Cu was reported to display laccase-like behaviour, oxidising phenolic substrates without a protein enzyme scaffold. In enzymatic reaction kinetics, GHK-Cu showed a Vmax of 1.735 × 10^-4 mM·s^-1 and a Km of 0.061 mM, which the authors described as good substrate affinity and excellent catalytic efficiency. A colorimetric assay built on this property detected epinephrine across a linear range of 20–240 μM with a limit of detection of 9.5 μM, and 2-aminophenol across 14–100 μM [4]. This is an in vitro analytical finding; it establishes catalytic competence of the complex, not a physiological role.

GHK-Cu and Th2 cytokine attenuation in keratinocyte models

A complex of Torilis japonica extract and GHK-Cu was formulated and examined for anti-atopic and skin-regenerative properties in TNF-α/interferon-γ-stimulated keratinocyte systems. The complex attenuated Th2 cytokines and promoted keratinocyte recovery, and the authors framed oxidative stress as an upstream amplifier of inflammatory signalling in atopic dermatitis [2]. The observation belongs to the extract–peptide complex in a cell-based model, so it cannot be assigned to GHK-Cu alone.

GHK-Cu and SIRT1/STAT3 signalling in a murine colitis model

In BALB/c mice with dextran sulfate sodium-induced ulcerative colitis, GHK-Cu was evaluated for therapeutic potential with emphasis on the NAD-dependent deacetylase SIRT1 and signal transducer and activator of transcription 3 (STAT3) pathway. The study was designed to define regulatory effects on that axis in a model of mucosal damage and impaired epithelial barrier function [6]. This is animal-only evidence; the pathway attribution is specific to the DSS colitis model.

GHK-Cu and behavioural rescue in middle-aged mice

Middle-aged mice treated with GHK-Cu by intraperitoneal or intranasal administration showed behavioural rescue, but the two routes produced divergent hippocampal aging programs [3]. The dissociation between a shared behavioural readout and route-dependent hippocampal signatures is the notable feature: the route of administration changed the molecular picture even where the behavioural result converged. Animal-only.

GHK-Cu and lifespan regulation in Caenorhabditis elegans

GHK-Cu was reported to delay aging in C. elegans through coordinated regulation of mitochondrial function and activation of the DAF-16/SKN-1 pathways [11]. DAF-16 and SKN-1 are the invertebrate orthologues of the FOXO and Nrf2 stress-response transcription factors, so this finding identifies a stress-resistance mechanism in a nematode model rather than a mammalian one.

GHK-Cu and inflammation attenuation in zebrafish larvae

In zebrafish larvae, GHK-Cu attenuated inflammation induced by copper sulfate or lipopolysaccharide [12]. The model uses two chemically distinct inflammatory challenges in the same organism, and the reported effect is attenuation of the induced inflammatory response. Aquatic larval model; not mammalian.

GHK-Cu and skin permeation from liposomal encapsulation

GHK-Cu is hydrophilic and shows limited permeation through the lipophilic stratum corneum, which constrains delivery to deeper skin layers. Liposomes capable of encapsulating the complex were discussed as a means of improving permeation potential [7]. This is a formulation and delivery question rather than a receptor mechanism, and the source is a review.

GHK-Cu and regenerative and antioxidant activity in preclinical models

A review of GHK-Cu in aesthetic medicine reports regenerative, anti-inflammatory and antioxidant properties demonstrated in preclinical models, and notes the age-related decline in tissue regenerative capacity as the rationale for interest in the compound [9]. The properties are attributed to preclinical work; no clinical mechanism is claimed.

GHK-Cu and combined ferment-extract formulations

A study of a Thermus thermophilus and Bacillus subtilis mixed-culture ferment extract augmented by GHK-Cu examined skin-beneficial effects against chronic inflammation and UV exposure, on the premise that cosmetic formulations often target several pathways at once [10]. As with the Torilis japonica work, the readout belongs to a multi-component formulation.

GHK-Cu and circulating levels in healthy adults

A two-part clinical trial is investigating GHK and GHK-Cu blood levels before and after intervention in healthy adults, and comparing the change from baseline to Day 8 between an X39 patch and a placebo patch [1]. The primary questions concern the magnitude of change in circulating levels and the between-arm difference. This is a measurement study in humans; it addresses exposure and pharmacokinetics rather than a mechanism of action.

GHK-Cu and acute skin wound healing

A trial is evaluating whether a topical gel containing GHK-Cu safely speeds healing of small, standardised punch-biopsy wounds in healthy adults compared with a matching vehicle gel, with each participant receiving both treatments under identical dressings and assessment over three weeks plus a scar-quality follow-up [5]. This is a human wound-healing endpoint study; results are not yet part of the evidence base summarised here.

Comparison of evidence by model

Model or system	Reported observation	Source
In vitro kinetics	Laccase-like catalysis; Vmax 1.735 × 10^-4 mM·s^-1, Km 0.061 mM	[4]
Keratinocytes (with Torilis japonica extract)	Th2 cytokine attenuation; keratinocyte recovery	[2]
Murine DSS colitis	SIRT1/STAT3 pathway regulation	[6]
Middle-aged mice	Behavioural rescue; divergent hippocampal programs by route	[3]
C. elegans	Delayed aging; DAF-16/SKN-1 activation	[11]
Zebrafish larvae	Attenuation of CuSO4- or LPS-induced inflammation	[12]
Human adults (measurement)	Circulating GHK/GHK-Cu change to Day 8 vs placebo	[1]
Human adults (wound healing)	Topical gel vs vehicle on punch-biopsy wounds	[5]

If you are reading this for personal health reasons

This material is sold for laboratory research only, and we do not provide dosing or medical guidance. Anyone considering a compound for themselves should speak to a licensed clinician.